Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Plos One|November 30, 2020
Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patientsRaoul Wochner, Dorothea Clauss, Johanna Nattenmüller, et al.Deutsches Arzteblatt International|August 22, 2019
Quality of Life, Fatigue, and Sleep Problems in Pancreatic Cancer Patients—A Randomized Trial on the Effects of ExerciseKaren Steindorf, Dorothea Clauss, Christine Tjaden, et al.Ebiomedicine|April 8, 2020
Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancerSusanne Roth, Katharina Zamzow, Matthias M Gaida, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 14, 2022
Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinomaCarl-Stephan Leonhardt, Ulf Hinz, Jörg Kaiser, et al.Journal of Hepato-Biliary-Pancreatic Sciences|December 2, 2022
Central pancreatectomy prevents postoperative diabetesRosa Klotz, Constanze Schilling, Charlotte Kuner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2024
Immunohistochemical FAP Expression Reflects <sup>68</sup>Ga-FAPI PET Imaging Properties of Low- and High-Grade Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal AdenocarcinomaAnna-Maria Spektor, Ewgenija Gutjahr, Matthias Lang, et al.European Journal of Radiology Open|June 17, 2024
Imaging differentiation of solid pseudopapillary neoplasms and neuroendocrine neoplasms of the pancreasEkaterina Khristenko, Matthias M Gaida, Christine Tjaden, et al.BMJ Open|September 4, 2020
Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce postoperative pancreatic fistula after distal pancreatectomy: the PREBOT<i>Pilot</i> trialUlla Klaiber, Peter Sauer, Eike Martin, et al.Plos One|June 17, 2014
Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumorsShereen Keleg, Alexandr Titov, Anette Heller, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 18, 2021
IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapyJoerg Kaiser, Cornelius Scheifele, Ulf Hinz, et al.Pageof 4